For example, one study attempted to investigate CTCs with epidermal growth factor receptor (EGFR) mutations before and after TKI treatment and found that an increase in the number of cells was associated with tumor progression, with the emergence of additional EGFR mutations in some cases [83]. The gene discussed is EGFR; the disease is neoplasm.